Anti-Inflammatory Activity of Three Kinds of Salvia and Its Active Compounds
![]() |
Shin, Han Jae
(KT&G Research Institute)
Gwak, Hyo Min (KT&G Research Institute) Jang, Mi (KT&G Research Institute) Park, Si Hwan (KT&G Research Institute) Min, Hye Jeong (KT&G Research Institute) Lee, Jeong Min (KT&G Research Institute) Lee, Moon Yong (KT&G Research Institute) Kim, Jong Han (KGC Research Institute) Kim, Sung Won (KGC Research Institute) Han, Chang Kyun (KGC Research Institute) Kim, Seung Hyung (Institute of Traditional Medicine and Bioscience, Daejeon University) |
1 | Barnes PJ, Chung KF and Page CP. (1998). Inflammatory mediators of asthma: An update. Pharmacological Reviews. 50:515-596. |
2 | Beasley R, Semprini A and Mitchell EA. (2015). Risk factors for asthma: Is prevention possible? The Lancet. 386:1075-1085. DOI |
3 | Choi JK, Oh HM, Park JH, Choi JH, Sa KH, Kang YM, Park PH, Shin TY, Rho MC and Kim SH. (2015a). Salvia plebeia extract inhibits the inflammatory response in human rheumatoid synovial fibroblasts and a murine model of arthritis. Phytomedicine. 22:415-422. DOI |
4 | Choi SI, Kwak H, Kim JY, Choi JG and Lee JH. (2015b). Antiadipogenic effects of Salvia plebeia R. Br. extracts by extraction conditions in 3T3-L1 preadipocytes. Korean Journal of Medicinal Crop Science. 23:245-252. DOI |
5 | Drazen JM, Israel E and O'Byrne PM. (1999). Treatment of asthma with drugs modifying the leukotriene pathway. New England Journal of Medicine. 340:197-206. DOI |
6 | Elias JA, Lee CG, Zheng T, Ma B, Homer RJ and Zhu Z. (2003). New insights into the pathogenesis of asthma. The Journal of Clinical Investigation. 111:291-297. DOI |
7 | Goulet JL, Byrum RS, Key ML, Nguyen M, Wagoner VA and Koller BH. (2000). Genetic factors determine the contribution of leukotrienes to acute inflammatory responses. The Journal of Immunology. 164:4899-4907. DOI |
8 | Jung HJ, Song YS, Lim CJ and Park EH. (2009). Antiinflammatory, anti-angiogenic and anti-nociceptive activities of an ethanol extract of Salvia plebeia R. Brown. Journal of Ethnopharmacology. 126:355-360. DOI |
9 | Liang Z, Xu Y, Wen X, Nie H, Hu T, Yang X, Chu X, Yang J, Deng X and He J. (2016). Rosmarinic acid attenuates airway inflammation and hyperresponsiveness in a murine model of asthma. Molecules. 21:769-774. DOI |
10 | Lim JA, Yun BW and Baek SH. (2007). Antioxidative activity and nitrite scavenging ability of methanol extract from Salvia plebeia R. Br. Korean Journal of Medicinal Crop Science. 15:183-188. |
11 | Maggi E. (1998). The TH1/TH2 paradigm in allergy. Immunotechnology. 3:233-244. DOI |
12 | Minoguchi K and Adachi M. (1999). Pathophysiology of asthma. In Cherniack NS, Altose MD, Homma I(ed.)., Rehabilitation of the patient with respiratory disease. McGraw-Hill. New York. NY, USA. p.97-104. |
13 | Pawankar R. (2001). Mast cells as orchestrators of the allergic reaction: The IgE-IgE receptor mast cell network. Current Opinion in Allergy and Clinical Immunology. 1:3-6. |
14 | Ren DB, Qin YH, Yun YH, Lu HM, Chen XQ and Liang YZ. (2014). Separation of nine compounds from Salvia plebeia R. Br. using two-step high-speed counter-current chromatography with different elution modes. Journal of Separation Science. 37: 2118-2125. DOI |
15 | Shimizu H, Obase Y, Katoh S, Mouri K, Kobashi Y and Oka M. (2013). Critical role of interleukin-5 in the development of a mite antigen-induced chronic bronchial asthma model. Inflammation Research. 62:911-917. DOI |
16 | Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL and Donaldson DD. (1998). Interleukin-13: Central mediator of allergic asthma. Science. 282:2258-2261. DOI |
17 | Wynn TA. (2015). Type 2 cytokines: Mechanisms and therapeutic strategies. Nature Reviews Immunology. 15:271-282. DOI |
![]() |